Skip to main content
Clinical Trials/EUCTR2016-004080-39-DK
EUCTR2016-004080-39-DK
Active, not recruiting
Phase 1

Determination of renal blood flow based on Rubidium-82 and PET-technology in healthy volunteers

Medicinsk Forskning, Regionshospitalet Holstebro, Hospitalsenheden Vest0 sites20 target enrollmentOctober 21, 2016

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Medicinsk Forskning, Regionshospitalet Holstebro, Hospitalsenheden Vest
Enrollment
20
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 21, 2016
End Date
May 28, 2018
Last Updated
4 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Medicinsk Forskning, Regionshospitalet Holstebro, Hospitalsenheden Vest

Eligibility Criteria

Inclusion Criteria

  • Age 18\-40 years, BMI 18,5\-30 kg/m2, women must use contraception
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 20
  • F.1\.3 Elderly (\>\=65 years) no
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Medical treatment in the last 2 weeks except for contraception, pregnancy or nursing, consumption of more than 14 units of alcohol for men and more than 7 for women per week, tobacco smoking, neoplasm, clinically significant heart, lung, liver, kidney, metanolic or neurologic disorders, clinically significant findings in blood samples, urine sample or ECG, office blood pressure \> 140/90mmHg, substance abuse

Outcomes

Primary Outcomes

Not specified

Similar Trials